If you have ever reached for cranberry juice to fend off a urinary tract infection, the amount inside the bottle probably matters more than the ritual. A 2026 narrative review in the Royal Society of Chemistry journal Food & Function pulled together the modern evidence on cranberry and bladder health, and pointed back to a specific daily dose of the plant's active compounds as the line between protection and no measurable effect.
That line is 36 milligrams of A-type proanthocyanidins per day, or PACs. In a meta-analysis of 10 randomized trials published in Frontiers in Nutrition, participants who took at least that much saw an 18 percent lower risk of recurrent UTIs compared with controls (RR 0.82, 95% CI 0.69 to 0.98). Below the threshold, the protective effect was not statistically significant.
Recurrent infections are the reason the dose matters. The CDC estimates that 50 to 80 percent of women will have at least one UTI in their lifetime, and 30 to 40 percent will have recurrent ones, defined by the agency as at least two infections in six months or three within a year.
How cranberry actually reaches the bladder
The mechanism is not what most people assume. Whole PAC molecules are poorly absorbed from the gut. Instead, gut bacteria break them down into smaller phenolic metabolites, which enter the bloodstream and are excreted in urine.
Those metabolites appear to interfere with the way pathogenic Escherichia coli latches on to the cells lining the bladder wall.
Without a grip, the bacteria are more easily flushed out before they can multiply into an infection. The same compounds have also been shown to disrupt biofilm formation, the sticky bacterial layer that helps infections persist.
None of this treats an active infection. Cranberry is a prevention tool for people prone to recurrence, and readers with UTI symptoms such as burning, urgency or blood in the urine should see a clinician for antibiotics rather than reach for a supplement.
The evidence stack behind the number
The Frontiers meta-analysis is not alone. A Cochrane review of 50 randomized trials with 8,857 participants found that cranberry products cut the risk of UTIs overall (RR 0.70, 95% CI 0.58 to 0.84), with the largest effect in children (RR 0.46) and a clear benefit in women with recurrent infections (RR 0.74). It found little or no benefit for elderly institutionalized adults, pregnant women or people with neurogenic bladder problems.
Also read: How your brain may be affected if you use AI every day
The Food and Function review reached a similar conclusion, framing high-dose, standardized cranberry extracts as a reasonable non-antibiotic option for people who keep getting infections, particularly women.
Why the label often does not match the dose
Getting to 36 mg from ordinary cranberry cocktail is difficult. Most sweetened cranberry drinks on supermarket shelves are diluted and sugared, and PAC content is rarely stated on the label at all.
Supplements are not automatically better. When Italian researchers analyzed 24 commercial cranberry supplements, actual PAC content per dosage unit ranged from 0.28 mg to 41.66 mg, a roughly 150-fold spread. Only 8 of the 24 products let a consumer reach 36 mg per day by following the label's recommended serving, and only six matched the PAC content declared on the label.
For shoppers, that leaves a short checklist. Look for products that state PAC content in milligrams per serving, not just total cranberry powder. Confirm the number refers to A-type proanthocyanidins measured by the BL-DMAC method, the standard used in the clinical studies. And check that the daily serving actually reaches at least 36 mg, since a bottle claiming "high potency" with no number attached is not a dose.
Also read: Your gut bacteria may reveal which IBS treatment will actually work for you
Also read: Ultra-processed diets linked to 26% higher risk of severe fatty liver disease
This article is made and published by Mie Hermansen, who may have used AI in the preparation.